PTCL Treatment
Aug 28, 2026
The Next Wave in Peripheral T-Cell Lymphoma Treatment: 4 Late-Stage Drugs Making Their Mark
Summary Peripheral T-cell lymphoma (PTCL) is a rare and aggressive group of mature T-cell malignancies, representing approximately 10–15% of non-Hodgkin lymphomas in the US. CHOP remains the standard first-line treatment, but its intensive cytotoxic profile limits use in some patients. ADCETRIS (brentuxi...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
